COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,757 Articles (22,943 medRxiv, 8,814 bioRxiv)

Most recent first Previous |  Page 42: Articles 411-420  | Next

Diagnostic Accuracy of an Immunoassay Using Avidity-Enhanced Polymeric Peptides for SARS-CoV-2 Antibody Detection
Pollo, B. A. L. V., Ching, D., Idolor, M. I., King, R. A., Climacosa, F. M., Caoili, S. E.
10.64898/2026.02.26.26343835 — Posted: 2026-03-02
IL-6 Receptor Antagonists and Severe Post-COVID-19 Outcomes: An Emulated Target Trial
Butzin-Dozier, Z., Kumar, M., Ji, Y., Wang, L.-C., Anzalone, A. J., Hurwitz, E., Patel, R. C., Wong, R., Bramante, C., Sines, B., on behalf of the National Clinical Cohort Collaborative
10.64898/2026.02.27.26347274 — Posted: 2026-03-02
Interplay of Immunity, Climate, and Viral Evolution Explains Semiannual SARS-CoV-2 Dynamics with Implications for Control
Bents, S. J., Bubar, K. M., Park, H. J., Tan, S. T., Baker, R., Mordecai, E. A., Lo, N. C.
10.64898/2026.02.27.26347213 — Posted: 2026-03-02
Microbiota-derived extracellular vesicles link intestinal dysbiosis to neuroimmune activation in long COVID
Aranguren, M., Doyon-Laliberte, K., Boncheva, I., Villard, A., Desjardins, A., Darbinian, E., Patel, S., DuSablon, C., Rivera Conde, E., Cabrera Munoz, D., Purchase, L., Piscopo, V. E. C., Alluli, A., Benaliouad, F., Sirois, J., Durcan, T., Masse, C., Mlaga, K. D., Chandrasekaran, P., Poudrier, J., Falcone, E. L.
10.64898/2026.02.28.708602 — Posted: 2026-03-02
Antigenic landscape of a highly mutated SARS-CoV-2 Spike in ongoing viral evolution
Turelli, P., Eray, E., Raclot, C., Trono, D., Antanasijevic, A.
10.64898/2026.02.27.708159 — Posted: 2026-02-27
Characterising associations between mental distress, mobility, and COVID-19 restrictions: a U.S. study
Fiandrino, S., Kulkarni, S., Cornale, P., Ghivarello, S., Birello, P., Parazzoli, S. M., Moss, F., De Gaetano, A., Liberatore, D., D'Ignazi, J., Kalimeri, K., Tizzani, M., Mazzoli, M.
10.64898/2026.02.26.26347164 — Posted: 2026-02-27
Temporary Shock or Lasting Scar? Life Expectancy Trajectories Since COVID-19
Dowd, J. B., Schöley, J., Polizzi, A., Aburto, J. M., Jaadla, H., Lei, H., Kashyap, R.
10.64898/2026.02.25.26347112 — Posted: 2026-02-27
Transition from infectivity and immune escape to pure escape as an evolutionary strategy during the COVID-19 pandemic.
Kotzen, B., Gurev, S., Youssef, N., Jaimes, J., Luban, J., Marks, D., Seaman, M., Lemieux, J. E.
10.64898/2026.02.26.706090 — Posted: 2026-02-27
Identifying severe COVID-19 risk variants modulating enhancer reporter activity in lung cells
Weykopf, G., Bickmore, W. A., Biddie, S. C., Friman, E. T.
10.64898/2026.02.26.708234 — Posted: 2026-02-26
The age paradox in post-infectious sequelae: physiological reserve outweighs chronological age in Long COVID susceptibility
Azhir, A., Cheng, J., Tian, J., Bassett, I. V., Patel, C. J., Klann, J. G., Murphy, S. N., Estiri, H.
10.64898/2026.02.24.26346989 — Posted: 2026-02-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).